E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/20/2005 in the Prospect News Biotech Daily.

Amgen estimates boosted by Thomas Weisel

Amgen Inc. earnings estimates were raised by Thomas Weisel Partners analyst Ian Somaiya to $3.17 per share from $2.86 for 2005 and to $3.37 from $3.29 for 2006 following second-quarter earnings, noting strong sales and an improved outlook for physician reaction to Medicare changes. Amgen shares Wednesday gained $10.65, or 15.10%, to $81.17 on volume of 81,042,901 shares versus the three-month running average of 8,010,400 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.